CD274 and pancreatic neoplasm: Gemcitabine has been observed to increase PD‐L1 across several models of pancreatic cancer, including established cell lines, primary cell line‐derived xenografts, murine cell lines, and a mouse model of pancreatic cancer.24, 138, 139